Updated: Do Pfizer’s monthly GLP-1 data justify Metsera’s $10B price tag?
更新：辉瑞的月度GLP-1数据能否支撑Metsera的100亿美元估值？

Pfizer said Tuesday that the monthly injection that was one of the cornerstones of its $10 billion buyout of Metsera allowed obesity patients to lose up to 10.5% of their weight, on a placebo-adjusted basis, after just over six months.
辉瑞周二表示，其以100亿美元收购Metsera交易的核心资产之一——每月注射剂——在安慰剂校正基础上，仅六个多月就可使肥胖患者减重最多10.5%。